Boustead Singapore acquires majority stake in Singapore urology robotics company for $6 mil

Teo Zheng Long07-03

UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis.Boustead Singapore F9D announced that its healthcare division, Boustead...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2648930006?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 12:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648930006","market":"hk","top_or_hot":-1,"title":"Boustead Singapore acquires majority stake in Singapore urology robotics company for $6 mil","media":"Teo Zheng Long","content":"<div>\n<p>UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis.Boustead Singapore F9D announced that its healthcare division, Boustead...</p>\n\n<a href=\"https://www.theedgesingapore.com/news/ma/boustead-singapore-acquires-majority-stake-singapore-urology-robotics-company-6-mil?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS\">Source Link</a>\n\n</div>\n","source":"edge_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boustead Singapore acquires majority stake in Singapore urology robotics company for $6 mil</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoustead Singapore acquires majority stake in Singapore urology robotics company for $6 mil\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-03 12:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.theedgesingapore.com/news/ma/boustead-singapore-acquires-majority-stake-singapore-urology-robotics-company-6-mil?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS><strong>Teo Zheng Long</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis.Boustead Singapore F9D announced that its healthcare division, Boustead...</p>\n\n<a href=\"https://www.theedgesingapore.com/news/ma/boustead-singapore-acquires-majority-stake-singapore-urology-robotics-company-6-mil?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DARP","symbol_name":"GRIZZLE GROWTH ETF","start_time":0,"source_url":"https://www.theedgesingapore.com/news/ma/boustead-singapore-acquires-majority-stake-singapore-urology-robotics-company-6-mil?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","article_id":"2648930006","we_media_id":null,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/ma/boustead-singapore-acquires-majority-stake-singapore-urology-robotics-company-6-mil?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2648930006","pubTimestamp":1783054104,"columns":[],"sourceInfo":{"source_id":"edge_highlight","name":"Edge"},"weMediaInfo":null,"summary":"UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis.","collect":0,"end_time":0,"defaultTopTitle":"theedgesingapore.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"DARP":"GRIZZLE GROWTH ETF","BK6520":"工商业服务概念","BK6045":"建筑与工程","DYNI":"IDX DYNAMIC INNOVATION ETF","KOMP":"SPDR S&P Kensho New Economies Composite ETF","F9D.SI":"宝德新加坡","BMCH":"BMC Stock Holdings, Inc."},"translate_title":"Boustead Singapore以600万美元收购新加坡泌尿机器人公司多数股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"F9D.SI":0.66,"BMCH":1,"DYNI":1.5,"KOMP":1.5,"DARP":1.5},"content_text":"UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis.Boustead Singapore F9D announced that its healthcare division, Boustead Medical Care Holdings (BMCH), has acquired a 60% stake in UroMedTech Pte Ltd (UroMedTech) through a $6 million equity injection. \nAccording to Boustead Singapore, UroMedTech is a Singapore-based medical technology company pioneering integrated robotic solutions for prostate cancer diagnosis through its UroMaster system, with a research and development roadmap to integrate focal therapy treatment within UroMaster. \n\"Founded by a team headed by Dr Wilson Gao, UroMedTech has established itself as an emerging innovator in urology robotics, which has secured regulatory approvals in multiple markets including Singapore, Malaysia, Australia and other parts of Asia,\" Boustead Singapore adds.\n\"We have filed for regulatory approvals in the US and the EU, and have sights on obtaining approvals in other global markets within the next few years,\" says Dr Wilson Gao, founder and CEO of UroMedTech.\nShares of Boustead Singapore closed 5 cents higher, or 2.45% up at $2.09 on July 3.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648930006","isCrawlerRequest":true}